Literature DB >> 6120166

Effect of GTP analogues on purified soluble guanylate cyclase.

H J Brandwein, J A Lewicki, S A Waldman, F Murad.   

Abstract

In our studies with purified soluble guanylate cyclase from rat lung, we have tested a number of guanosine 5'-triphosphate (GTP) analogues as substrates and inhibitors, 5'-Guanylylimidodiphosphate (GMP-P(NH)P), guanylyl (beta, gamma-methylene) diphosphate (GMP-P(CH2)P), and guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) were found to be substrates for guanylate cyclase. GTP gamma S supported cyclic GMP formation at 20 or 75% of the rate seen with Mn2+-GTP and Mg2+-GTP, respectively. GMP-P(NH)P and GMP P(CH2)P supported cyclic GMP formation at 10-20% of the GTP rate with either cation cofactor. These analogues were found to have multiple Km values; one Km value was similar to GTP (150 microM with Mg2+, 20-70 microM with Mn2+), but an additional high affinity catalytic site (3 microM) was also observed. Guanosine tetraphosphate (Ki = 10 microM), adenosine triphosphate (Ki = 9 microM) and the 2'3'-dialdehyde derivative of GTP (dial GTP) (Ki = 1 microM) were not good substrates for the enzyme; however, they were potent competitive inhibitors. These GTP analogues will be useful tools for the study of GTP binding sites on guanylate cyclase and they may also help elucidate the effects of free radicals and other agents on guanylate cyclase regulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120166

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

2.  Human recombinant soluble guanylyl cyclase: expression, purification, and regulation.

Authors:  Y C Lee; E Martin; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase.

Authors:  Paul D Baum; Paul M Sullam; Cheryl A Stoddart; Joseph M McCune
Journal:  AIDS       Date:  2011-11-28       Impact factor: 4.177

4.  Distinct inhibitory ATP-regulated modulatory domain (ARMi) in membrane guanylate cyclases.

Authors:  T Duda; R Goraczniak; R K Sharma
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Interactive effects of isoprenaline, forskolin and acetylcholine on Ca2+ current in frog ventricular myocytes.

Authors:  R Fischmeister; A Shrier
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

6.  Highly purified particulate guanylate cyclase from rat lung: characterization and comparison with soluble guanylate cyclase.

Authors:  S A Waldman; J A Lewicki; L Y Chang; F Murad
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  Regulation of Ca2+ current in frog ventricular cardiomyocytes by 5'-guanylylimidodiphosphate and acetylcholine.

Authors:  T D Parsons; A Lagrutta; R E White; H C Hartzell
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

8.  Structural insights into the mechanism of human soluble guanylate cyclase.

Authors:  Yunlu Kang; Rui Liu; Jing-Xiang Wu; Lei Chen
Journal:  Nature       Date:  2019-09-12       Impact factor: 49.962

Review 9.  Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.

Authors:  Natasha M Rogers; Franziska Seeger; Elsa D Garcin; David D Roberts; Jeffrey S Isenberg
Journal:  Front Physiol       Date:  2014-04-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.